Silencing of PD-L1 efficiently boosted the anti-tumor effect of cetuximab on cell proliferation (Fig. 6C, D) and apoptosis (Fig. 6E), additionally, these effects mediated by PD-L1 knockdown could be counteracted by SOX12 upregulation (Fig. 6C–E). This evidence concerns the gene SOX12 and neoplasm.